Back to results
US 8,278,301 B2Granted
2-alkylbenzoxazole carboxamides as 5HT3 modulators
AssigneeAlbany Molecular Research, Inc.
InventorsDavid D. Manning, Zhicai Yang
Life of this patent
Estimating the term…
Abstract
Compounds of formulae I and II: are disclosed as 5-HT3 inhibitors. Those compounds are useful in treating CINV, IBS-D and other diseases and conditions.
Claims4
A method of treating irritable bowel syndrome, emesis, or post-operative nausea or vomiting, which comprises administering to a patient in need of such treatment a therapeutically effective amount of a compound of formula
- wherein
- R1, R2 and R3 are independently selected from the group consisting of hydrogen, halogen, amino, alkylamino, dialkylamino, acylamino, morpholinyl, —O-loweralkyl, hydroxy, loweralkyl, fluoroloweralkyl, —O-lowerfluoroalkyl, methylenedioxy, ethylenedioxy, alkoxy-loweralkyl and hydroxyloweralkyl;
- R4 is a residue selected from the group consisting of:
- (i) a saturated nitrogen heterocycle or methyl-substituted saturated nitrogen heterocycle, in which said nitrogen is tertiary, said heterocycle containing at least one 5 or 6-membered ring;
- and
- (ii) an imidazolylalkyl residue wherein the imidazole of said imidazolylalkyl is optionally substituted with up to three groups chosen from halogen, (C1-C4)alkyl, substituted (C1-C4)alkyl and NH2;
- and
- R10 is selected from the group consisting of
- (i) hydrogen;
- (ii) (C1-C10)alkyl;
- (iii) substituted (C1-C10)alkyl;
- (iv) saturated C-attached heterocyclyl;
- and
- (v) substituted, saturated C-attached heterocyclyl.
11 more elements
Dependencies are inferred from the claim text.